ArticleMolecular therapy. Methods & clinical development2024

Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis.

Karen J Quadrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.